Follow
Niranjan Jeganathan
Niranjan Jeganathan
Loma Linda University Health
Verified email at llu.edu
Title
Cited by
Cited by
Year
Connective tissue disease-related interstitial lung disease: prevalence, patterns, predictors, prognosis, and treatment
N Jeganathan, M Sathananthan
Lung 198 (5), 735-759, 2020
602020
The characteristics and impact of source of infection on sepsis-related ICU outcomes
N Jeganathan, S Yau, N Ahuja, D Otu, B Stein, L Fogg, R Balk
Journal of critical care 41, 170-176, 2017
562017
Current trends in sepsis-related mortality in the United States
J Prest, M Sathananthan, N Jeganathan
Critical care medicine 49 (8), 1276-1284, 2021
532021
Mortality trends of idiopathic pulmonary fibrosis in the United States from 2004 through 2017
N Jeganathan, RA Smith, M Sathananthan
Chest 159 (1), 228-238, 2021
382021
Rac1-mediated cytoskeleton rearrangements induced by intersectin-1s deficiency promotes lung cancer cell proliferation, migration and metastasis
N Jeganathan, D Predescu, J Zhang, F Sha, C Bardita, M Patel, S Wood, ...
Molecular Cancer 15, 1-17, 2016
342016
Alk5/Runx1 signaling mediated by extracellular vesicles promotes vascular repair in acute respiratory distress syndrome
T Shah, S Qin, M Vashi, DN Predescu, N Jeganathan, C Bardita, ...
Clinical and translational medicine 7, 1-18, 2018
302018
The prevalence and burden of interstitial lung diseases in the USA
N Jeganathan, M Sathananthan
ERJ Open Research 8 (1), 2022
242022
Acute hemorrhagic leukoencephalopathy associated with influenza A (H1N1) virus
N Jeganathan, M Fox, J Schneider, D Gurka, T Bleck
Neurocritical care 19, 218-221, 2013
232013
Ventilator liberation for high-risk-for-failure patients: improving value of the spontaneous breathing trial
N Jeganathan, CA Kaplan, RA Balk
Respiratory Care 60 (2), 290-296, 2015
202015
Rheumatoid arthritis and associated interstitial lung disease: mortality rates and trends
N Jeganathan, E Nguyen, M Sathananthan
Annals of the American Thoracic Society 18 (12), 1970-1977, 2021
192021
Characteristics and outcomes of patients with and without type 2 diabetes mellitus and pulmonary sepsis
M Sathananthan, A Sathananthan, N Jeganathan
Journal of Intensive Care Medicine 35 (9), 836-843, 2020
162020
Sepsis-related mortality rates and trends based on site of infection
J Prest, T Nguyen, T Rajah, AB Prest, M Sathananthan, N Jeganathan
Critical Care Explorations 4 (10), e0775, 2022
132022
Modulation of intersectin-1s lung expression induces obliterative remodeling and severe plexiform arteriopathy in the murine pulmonary vascular bed
M Patel, D Predescu, C Bardita, J Chen, N Jeganathan, M Pritchard, ...
The American journal of pathology 187 (3), 528-542, 2017
132017
Impact of end-stage renal disease and acute kidney injury on ICU outcomes in patients with sepsis
N Jeganathan, N Ahuja, S Yau, D Otu, B Stein, RA Balk
Journal of Intensive Care Medicine 32 (7), 444-450, 2017
102017
The characteristics and outcomes of patients with idiopathic pulmonary fibrosis admitted to the ICU with acute respiratory failure
RA Smith, M Sathananthan, P Kaur, N Jeganathan
Heart & Lung 50 (1), 192-196, 2021
92021
Patients with idiopathic pulmonary fibrosis admitted to the ICU with acute respiratory failure—a reevaluation of the risk factors and outcomes
M Schrader, M Sathananthan, N Jeganathan
Journal of Intensive Care Medicine 37 (3), 342-351, 2022
82022
A short review: Complementary and alternative medicine in lung cancer
R Parikh, N Jeganathan
Journal of Ancient Diseases Preventive Remedies 2, 2014
72014
Intersectin-1s deficiency in pulmonary pathogenesis
N Jeganathan, D Predescu, S Predescu
Respiratory Research 18, 1-10, 2017
62017
The association of pulmonary fibrosis with diabetes mellitus
N Jeganathan, C Miot, A Sathananthan, M Sathananthan
ERJ Open Research 6 (4), 2020
52020
The association of lung cancer with pulmonary fibrosis
N Jeganathan, D Cleland, M Sathananthan
ERJ Open Research 8 (1), 2022
42022
The system can't perform the operation now. Try again later.
Articles 1–20